Medicine
Miconazole 200 mg vaginal suppository
Miconazole 200 mg vaginal suppository is a generic prescription medicine for vaginal use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Miconazole
- Brand
- Sold under the generic name
- Strength
- 200 mg
- Dosage form
- Vaginal suppository
- Route
- Vaginal
- Packs
- 3 suppositories
- Manufacturer
- Actavis Pharma
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 January 1995
- Identifiers
- RxCUI 992765DailyMed set ID aa9e250b-f317-42cb-b8d2-e85de56f4ef7NDC 0472-1738Application ANDA073508
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 suppository in 1 carton | 0472-1738-03 | Actavis Pharma | 18 January 1995 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 January 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Miconazole
Clinical summary
Miconazole is an azole antifungal indicated for the local treatment of oropharyngeal candidiasis (OPC) in adults. It is available as buccal tablets and vaginal suppositories. MedsAcross supplies Miconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MiconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Oravig prescribing information (Galt Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Miconazole 200 mg vaginal suppository for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.